Wednesday, November 18, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Analysis

Major Investors Exit Altria Despite Compelling Valuation

Felix Baarz by Felix Baarz
November 24, 2025
in Analysis, Consumer & Luxury, Dividends, Value & Growth
0
Altria Stock
0
SHARES
131
VIEWS
Share on FacebookShare on Twitter

A significant divergence is emerging for Altria Group, the company behind Marlboro cigarettes. While corporate leadership commits billions to share repurchases and the stock trades near historic valuation lows, institutional heavyweights are quietly reducing their exposure. This creates a puzzling scenario: the tobacco giant appears fundamentally inexpensive, yet professional investors are heading for the exits, raising questions about potential unseen risks.

Aggressive Buybacks Meet Tepid Investor Sentiment

The company’s latest quarterly report presented a mixed picture. Although earnings per share came in at $1.45, slightly surpassing estimates of $1.44, the top line disappointed. Revenue of $5.25 billion represented a 3.0% year-over-year decline and fell short of the $5.31 billion consensus forecast.

In response, management launched an aggressive capital return initiative, authorizing a $2.0 billion share buyback program. This strategic move is designed to bolster the share price and signals the executive team’s confidence in the firm’s enduring profitability. However, this substantial financial commitment has so far failed to convince major shareholders to maintain their positions.

Institutional Selling Gains Momentum

Fresh data revealed this week that Franklin Resources Inc. has substantially pared down its stake in Altria. The investment firm slashed its position by 9.0%, disposing of 257,417 shares and reducing its total holding to approximately 2.6 million shares.

Should investors sell immediately? Or is it worth buying Altria?

Franklin Resources is not alone in its retreat. Longfellow Investment Management has also been divesting its Altria holdings, contributing to the prevailing selling pressure. This institutional skepticism is particularly notable given that the stock has already declined by 10% over the past month. Such a pullback would typically attract value-oriented buyers, yet major asset managers currently appear more focused on risk mitigation than on perceived opportunities within the tobacco sector.

The Valuation Conundrum Deepens

From a fundamental perspective, Altria’s metrics suggest substantial undervaluation. The stock currently trades at a Price-to-Earnings (P/E) ratio of 11.0, significantly below the industry average of 14.3. Analysis from Simply Wall St. presents an even starker picture: their assessment, based on discounted cash flow models, indicates the shares may be trading 43.9% below their fair value.

This creates a remarkable disconnect between traditional valuation measures and market sentiment. The market appears to be pricing in substantial regulatory headwinds or structural challenges within the industry, seemingly overlooking the company’s continued robust cash flow generation. This very tension between price and perceived value is defining the current trading dynamic for Altria shares. The critical question remains whether a $2 billion buyback program can stem the growing institutional exodus.

Ad

Altria Stock: Buy or Sell?! New Altria Analysis from November 17 delivers the answer:

The latest Altria figures speak for themselves: Urgent action needed for Altria investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from November 17.

Altria: Buy or sell? Read more here...

Tags: Altria
Felix Baarz

Felix Baarz

My name is Felix Baarz, and I look back on over fifteen years of experience as a business journalist. I have always been fascinated by the mechanisms and dynamics of global financial markets as well as the complex economic and political interconnections that shape our world. With this passion, I have made a name for myself as an expert on international financial markets and dedicate myself with great commitment to making even the most complex topics understandable and accessible to my readers. My roots lie in Cologne, where I was born and raised. Early on, my curiosity about economic topics and international developments sparked my interest in journalism. After completing my studies, I began my career as a business editor at a respected German trade publication. Here I laid the foundation for my professional career, but my curiosity soon drew me out into the wider world. A turning point in my life was moving to New York, where I lived for six years and gained insight into leading media houses. In this vibrant metropolis, I was able to report firsthand from the heart of the global financial world. From daily developments on Wall Street to major economic policy decisions that make waves worldwide, I had the opportunity to write about central topics that move people and markets alike. This time shaped my perspective and sharpened my view of global interconnections.

Related Posts

SAP Stock
Analysis

SAP’s Buyback Machine Grinds On, But the Analyst Chorus Is Turning Sour

September 7, 2026
Münchener Rück Stock
Analysis

Munich Re’s Monte Carlo Warning Collides With Wall Street’s Widest Analyst Split in Years

September 7, 2026
Xiaomi Stock
Asian Markets

Xiaomi’s September Tightrope: A Foldable Counterpunch Against Apple While EV Targets Slip

September 7, 2026
Next Post
Tilray Stock

Tilray Gains Strategic Foothold in Québec's Newly Legalized Vape Market

Kraft Heinz Stock

Kraft Heinz: Dividend Allure Masks Deeper Troubles

Applovin Stock

Applovin Shares Navigate Market Volatility

Recommended

Mirum Pharmaceuticals Stock

Mirum Pharmaceuticals: A Pivotal Year of Clinical Catalysts and Financial Milestones

8 months ago
Marvell Technology Stock

Marvell Technology’s AI Business Fuels Record Quarter Amid Mixed Segment Performance

1 year ago
Ondas Holdings Stock

Ondas Holdings: Can New Contracts Reignite Its Stalled Momentum?

12 months ago
Block Stock

A Tale of Two Titans: Block and PayPal’s Divergent Fintech Paths

1 year ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum DroneShield Eli Lilly FALLBACK Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Netflix Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power Robinhood Rocket Lab USA Salesforce Strategy Take-Two Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics XRP
No Result
View All Result

Highlights

Bitcoin Slips Below $70,000, and a Samsung Rumor Lifts Modine

Huang Exits, Cisco Reports: Who Actually Gets Paid for AI

The AI Rebound Gets an Audit: Who Earns, Who Borrows

A Hot CPI Reading Stalls the Rebound and Puts a December Hike in Play

Cash Over Stories: Take-Two, Cisco and Nvidia Face Their Tests

Four Down Weeks for the Nasdaq, and Consumer Stocks Quietly Cash In

Trending

Home Depot Stock
Newsletter

Home Depot Beats, Shares Slip: Bigger Tickets, Fewer Customers

by Stephanie Dugan
November 17, 2026
0

Dear readers, Home Depot did what it was supposed to do on Tuesday morning and got little...

Bitcoin Stock

Rotation, Not Panic: Retailers Test Where Tech’s Money Went

November 16, 2026
Cisco Stock

At 5.15%, the 10-Year Treasury Picks the Winners

November 14, 2026
Bitcoin Stock

Bitcoin Slips Below $70,000, and a Samsung Rumor Lifts Modine

November 13, 2026
Cisco Stock

Huang Exits, Cisco Reports: Who Actually Gets Paid for AI

November 12, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Home Depot Beats, Shares Slip: Bigger Tickets, Fewer Customers
  • Rotation, Not Panic: Retailers Test Where Tech’s Money Went
  • At 5.15%, the 10-Year Treasury Picks the Winners

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com